RxDoctor Payments Data

Justin Ossman, MD

Family Medicine · Chattanooga, TNNPI 1982946091

Payments from drug & device makers

$3,186in general payments, 2019–2025

Across 179 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$585
  • AbbVie$495
  • Pfizer$332
  • AstraZeneca$265
  • Abbott$207
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$149
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,186 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$79,292
Medicare patients
226
Services billed
3,518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide63$107,613
JardianceEmpagliflozin87$92,589
MounjaroTirzepatide63$91,422
EliquisApixaban63$75,041
Breztri AerosphereBudesonide/Glycopyr/Formoterol60$37,357
FarxigaDapagliflozin Propanediol37$35,302
TrulicityDulaglutide27$33,337
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$24,427
LinzessLinaclotide19$17,377
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$15,459
JanuviaSitagliptin Phosphate14$12,667
BelsomraSuvorexant17$7,351
Fiasp FlextouchInsulin Aspart (Niacinamide)11$5,980
Spiriva HandihalerTiotropium Bromide11$5,430
Tresiba Flextouch U-100Insulin Degludec11$5,271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$46$124,75990 claims
Novo NordiskOzempic$585$107,61363 claims
Boehringer IngelheimJardiance$90$92,58987 claims
PfizerEliquis$332$75,04163 claims
AstraZenecaBreztri Aerosphere, Farxiga$265$72,65997 claims
GSKTrelegy Ellipta, Anoro Ellipta$118$39,88768 claims
AbbVieLinzess$495$17,37719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →